Methyl 2-(4-aminophenyl)-2-hydroxyacetate, 98%, 10g

2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one>97.0%(N)1g

4-[4-(1,1-Dimethylethyl)phenyl]-1H-pyrazole, 100mg

(R)-1-(2,4,5-Trifluorophenyl)ethan-1-ol, 250mg

3-Fluoro-4-methylbenzoic acid, 97.0%, 1g

4'-bromo-3-(3,4-dimethylphenyl)-2'-fluoropropiophenone, 97.0%, 1g

3-Chloro-o-xylene, 98.0%, 100g

2-Methoxy-6-methylnicotinic acid, 98+%, 1g

3-(5-bromo-2-methoxyphenyl)propanoic acid, 95.0%, 10g

2-Bromo-4-iodobenzamide, 97.0%, 10g

Galunisertib, 95.0%, 100mg

(2-methyl-1-benzofuran-7-yl)amine hydrochloride, 95.0%, 5g

3-Amino-1,6-dihydropyrazolo[3,4-c]pyrazole, 95.0%, 250mg